Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Daniel Merrick

Concepts (305)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
40
2023
2159
3.120
Why?
Precancerous Conditions
10
2023
155
2.170
Why?
Carcinoma, Squamous Cell
14
2023
577
1.910
Why?
Carcinoma, Non-Small-Cell Lung
13
2023
959
1.430
Why?
Adenocarcinoma
7
2019
787
0.690
Why?
Bronchi
6
2018
223
0.490
Why?
Chemoprevention
4
2019
87
0.460
Why?
Biopsy
8
2023
1024
0.440
Why?
Disease Progression
7
2019
2371
0.430
Why?
Biomarkers, Tumor
8
2018
1032
0.420
Why?
ErbB Receptors
6
2023
554
0.420
Why?
Carmustine
3
2020
47
0.390
Why?
Heat-Shock Proteins
1
2012
112
0.380
Why?
Neovascularization, Pathologic
5
2015
280
0.380
Why?
Bronchial Neoplasms
2
2011
13
0.360
Why?
Papillomaviridae
4
1996
101
0.350
Why?
Lung Diseases
1
2015
690
0.320
Why?
Polymorphism, Genetic
1
2012
610
0.320
Why?
Smoke
3
2020
123
0.320
Why?
Keratinocytes
4
1996
215
0.320
Why?
Proto-Oncogene Proteins
3
2018
607
0.310
Why?
Smoking
6
2019
1382
0.310
Why?
Inflammation
1
2018
2464
0.300
Why?
Gene Dosage
3
2016
129
0.290
Why?
Gene Expression Regulation, Neoplastic
6
2018
1145
0.290
Why?
Carcinogenesis
2
2020
175
0.290
Why?
B7-H1 Antigen
2
2019
137
0.290
Why?
Epoprostenol
2
2018
133
0.270
Why?
Iloprost
4
2018
46
0.260
Why?
Carcinogens
5
2018
102
0.260
Why?
Cell Transformation, Neoplastic
3
2023
307
0.260
Why?
Mice
21
2023
14843
0.240
Why?
Mutation
6
2023
3338
0.240
Why?
Humans
49
2023
114049
0.240
Why?
In Situ Hybridization, Fluorescence
3
2018
308
0.230
Why?
Sputum
4
2019
286
0.230
Why?
Receptor, ErbB-2
1
2006
300
0.220
Why?
Immunohistochemistry
5
2015
1624
0.220
Why?
Lung
9
2023
3521
0.220
Why?
Cardiomyopathy, Hypertrophic, Familial
1
2003
16
0.220
Why?
Neoplasm Invasiveness
4
2015
438
0.210
Why?
Chest Pain
1
2003
82
0.210
Why?
Cell Proliferation
4
2018
2173
0.210
Why?
Desmoglein 3
2
2022
17
0.210
Why?
Epithelial-Mesenchymal Transition
3
2022
167
0.200
Why?
Lidocaine
1
2022
40
0.200
Why?
Gelatin
1
2022
36
0.200
Why?
Female
29
2022
59326
0.200
Why?
Vascular Endothelial Growth Factor A
1
2005
496
0.200
Why?
Middle Aged
18
2020
26607
0.200
Why?
Male
28
2020
55398
0.200
Why?
Neuropilin-1
1
2021
9
0.200
Why?
Ki-67 Antigen
2
2015
102
0.190
Why?
Aged
13
2019
18971
0.190
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
86
0.180
Why?
Air Pollution
1
2023
169
0.180
Why?
Disease Models, Animal
5
2020
3498
0.180
Why?
Cysts
1
2021
92
0.180
Why?
Receptor, IGF Type 1
2
2010
58
0.170
Why?
Animals
21
2023
31565
0.170
Why?
Air Pollutants
1
2023
244
0.170
Why?
Drug Resistance, Neoplasm
3
2023
636
0.170
Why?
Cell Cycle Proteins
2
2018
549
0.170
Why?
Granulomatosis with Polyangiitis
1
2020
41
0.170
Why?
Gene Expression Profiling
2
2005
1518
0.160
Why?
Respiratory System
1
2020
137
0.160
Why?
Carcinoma in Situ
1
2019
44
0.160
Why?
Exons
1
2020
301
0.160
Why?
gamma Catenin
1
2018
17
0.150
Why?
Fluorescent Antibody Technique
1
2019
396
0.150
Why?
MicroRNAs
2
2016
600
0.150
Why?
Metaplasia
1
2018
54
0.150
Why?
Aged, 80 and over
7
2017
6307
0.150
Why?
Bronchial Diseases
1
2018
35
0.150
Why?
Mucin 5AC
1
2018
48
0.150
Why?
Protein Kinase Inhibitors
3
2023
784
0.150
Why?
Cell Cycle Checkpoints
1
2018
84
0.150
Why?
Anticarcinogenic Agents
1
2018
66
0.150
Why?
Tobacco Smoke Pollution
1
2020
217
0.150
Why?
RNA, Messenger
5
2022
2550
0.140
Why?
Head and Neck Neoplasms
1
2021
427
0.140
Why?
Lymphocytes, Tumor-Infiltrating
1
2017
111
0.140
Why?
Urethane
4
2023
41
0.130
Why?
Cell Transformation, Viral
2
1993
24
0.130
Why?
Myocardial Infarction
1
2003
932
0.130
Why?
Antigen Presentation
1
2017
188
0.130
Why?
Frizzled Receptors
1
2016
22
0.130
Why?
Oncogene Proteins, Fusion
1
2018
179
0.130
Why?
Adult
11
2018
30377
0.130
Why?
Proto-Oncogene Proteins c-met
1
2016
67
0.130
Why?
Oncogenes
1
2016
104
0.130
Why?
Porphyrins
1
2015
16
0.130
Why?
Tomography, Spiral Computed
1
2015
23
0.130
Why?
Topoisomerase Inhibitors
1
2015
4
0.120
Why?
Smad4 Protein
1
2015
34
0.120
Why?
Protein-Tyrosine Kinases
1
2018
393
0.120
Why?
Bronchopulmonary Dysplasia
1
2019
333
0.120
Why?
Mice, Transgenic
5
2018
1947
0.110
Why?
Chromosomal Instability
1
2013
18
0.110
Why?
Macrophages, Alveolar
2
2023
348
0.110
Why?
Stem Cells
1
2018
541
0.110
Why?
Microarray Analysis
1
2013
118
0.110
Why?
Neoplasms, Basal Cell
1
2013
3
0.110
Why?
Endoscopy
1
2015
245
0.110
Why?
Trachea
1
2015
223
0.110
Why?
Prognosis
5
2020
3315
0.100
Why?
Tretinoin
1
1993
122
0.100
Why?
Piperidines
2
2012
159
0.100
Why?
B-Lymphocytes
1
2017
762
0.100
Why?
Quinazolines
2
2012
240
0.100
Why?
Interleukin-1
1
1996
965
0.100
Why?
Cohort Studies
3
2023
4883
0.100
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1356
0.100
Why?
Early Detection of Cancer
1
2015
305
0.100
Why?
PTEN Phosphohydrolase
1
2013
140
0.100
Why?
Receptors, Transforming Growth Factor beta
1
2012
52
0.100
Why?
Antigens, Differentiation
1
1992
79
0.100
Why?
CD4-Positive T-Lymphocytes
1
2017
959
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2012
924
0.090
Why?
Cell Line
4
2019
2629
0.090
Why?
Hyperplasia
1
2011
163
0.090
Why?
Diagnosis, Differential
3
2021
1331
0.090
Why?
Pulmonary Disease, Chronic Obstructive
1
2018
907
0.090
Why?
Tissue Array Analysis
3
2019
48
0.090
Why?
Epithelium
4
2018
295
0.090
Why?
Receptor Protein-Tyrosine Kinases
1
2012
224
0.090
Why?
Pulmonary Surgical Procedures
1
2010
7
0.090
Why?
Nuclear Proteins
3
2006
591
0.090
Why?
Small Cell Lung Carcinoma
1
2010
77
0.080
Why?
Epithelial Cells
4
2018
946
0.080
Why?
Pulmonary Alveoli
1
2012
372
0.080
Why?
Follow-Up Studies
2
2015
4392
0.080
Why?
Neoplasm Staging
3
2020
1162
0.080
Why?
Vasodilator Agents
1
2011
302
0.080
Why?
Cell Polarity
1
2010
131
0.080
Why?
Enzyme-Linked Immunosorbent Assay
2
2005
787
0.080
Why?
Receptors, Fibroblast Growth Factor
1
2008
63
0.080
Why?
Solitary Fibrous Tumor, Pleural
1
2008
3
0.080
Why?
Osteoarthropathy, Secondary Hypertrophic
1
2008
4
0.080
Why?
Echocardiography
2
2003
569
0.080
Why?
Smokers
2
2019
129
0.070
Why?
Neoplasms, Experimental
2
2018
149
0.070
Why?
Genome-Wide Association Study
1
2013
1176
0.070
Why?
Fibroblast Growth Factors
1
2008
162
0.070
Why?
Carcinoma, Small Cell
1
2008
158
0.070
Why?
Monocytes
1
2010
503
0.070
Why?
Gene Expression Regulation
1
2016
2322
0.070
Why?
Edema
1
2008
119
0.070
Why?
Biomarkers
4
2023
3397
0.070
Why?
Radiography, Thoracic
1
2008
150
0.070
Why?
Tumor Microenvironment
2
2021
428
0.070
Why?
Treatment Outcome
5
2022
9049
0.070
Why?
Hydrogels
2
2023
573
0.070
Why?
Prevalence
2
2023
2247
0.070
Why?
Polymorphism, Single Nucleotide
1
2013
1880
0.070
Why?
Minichromosome Maintenance Complex Component 2
1
2006
4
0.070
Why?
Placebos
2
2019
197
0.060
Why?
Hypoxia
1
2012
956
0.060
Why?
Transcription Factors
1
1993
1526
0.060
Why?
Mice, Inbred A
2
2020
45
0.060
Why?
Chromosome Aberrations
2
2017
134
0.060
Why?
Proto-Oncogene Proteins p21(ras)
2
2018
228
0.060
Why?
Prospective Studies
4
2023
6195
0.060
Why?
Bronchoscopy
2
2019
196
0.060
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
103
0.060
Why?
Japan
1
2003
85
0.050
Why?
Gene Knockdown Techniques
2
2015
301
0.050
Why?
Signal Transduction
3
2012
4501
0.050
Why?
Aniline Compounds
1
2023
70
0.050
Why?
Formaldehyde
1
2022
46
0.050
Why?
Diagnostic Errors
1
2003
150
0.050
Why?
Alveolar Epithelial Cells
1
2023
93
0.050
Why?
Keratin-5
1
2022
46
0.050
Why?
Up-Regulation
1
2005
802
0.050
Why?
Molecular Targeted Therapy
2
2018
347
0.050
Why?
Particle Size
1
2023
317
0.050
Why?
Mice, Inbred BALB C
2
2011
1144
0.050
Why?
Sensitivity and Specificity
1
2006
1690
0.050
Why?
Double-Blind Method
2
2019
1656
0.050
Why?
Immunoenzyme Techniques
2
2012
192
0.050
Why?
Adaptive Immunity
1
2023
154
0.050
Why?
Tubulin
1
2022
122
0.050
Why?
Interferon-gamma
2
2018
719
0.050
Why?
Particulate Matter
1
2023
185
0.050
Why?
Incidence
2
2008
2314
0.050
Why?
PPAR gamma
1
2022
182
0.050
Why?
Pain, Postoperative
1
2022
190
0.050
Why?
Exercise Test
1
2003
547
0.040
Why?
Acute Disease
1
2003
908
0.040
Why?
Electrocardiography
1
2003
561
0.040
Why?
Oximes
1
2020
19
0.040
Why?
Breast Neoplasms
1
2011
1846
0.040
Why?
Blotting, Western
2
2012
1143
0.040
Why?
Environmental Exposure
1
2023
372
0.040
Why?
Mice, Inbred C57BL
2
2023
4680
0.040
Why?
Pyrimidinones
1
2020
88
0.040
Why?
Mass Screening
2
2004
979
0.040
Why?
Rituximab
1
2020
148
0.040
Why?
Amino Acid Substitution
1
2020
261
0.040
Why?
RNA
1
2005
806
0.040
Why?
T-Lymphocytes, Regulatory
1
2021
337
0.040
Why?
Pyridones
1
2020
122
0.040
Why?
Imidazoles
1
2020
203
0.040
Why?
Diagnostic Imaging
1
2021
278
0.040
Why?
Cell Line, Transformed
2
1996
133
0.040
Why?
Remission Induction
1
2019
233
0.040
Why?
Risk Factors
3
2019
8614
0.040
Why?
Tobacco Smoking
1
2018
21
0.040
Why?
Intramolecular Oxidoreductases
1
2018
57
0.040
Why?
Tricuspid Valve
1
1998
27
0.040
Why?
RNA, Small Interfering
2
2012
534
0.040
Why?
Proto-Oncogene Proteins B-raf
1
2020
191
0.040
Why?
Time
1
2018
70
0.040
Why?
Cytochrome P-450 Enzyme System
1
2018
108
0.040
Why?
Immunotherapy
1
2021
473
0.040
Why?
Ventricular Outflow Obstruction
1
1998
38
0.040
Why?
Tumor Burden
1
2018
258
0.040
Why?
Lymphocyte Count
1
2017
132
0.040
Why?
DNA Copy Number Variations
1
2018
153
0.040
Why?
Antigen-Presenting Cells
1
2017
150
0.030
Why?
Carcinogenicity Tests
1
1996
5
0.030
Why?
Structure-Activity Relationship
1
2018
499
0.030
Why?
Blotting, Northern
1
1996
193
0.030
Why?
Cells, Cultured
2
2016
3861
0.030
Why?
Neoplasms, Glandular and Epithelial
1
1996
34
0.030
Why?
Neoplasms
1
2010
2086
0.030
Why?
Immunophenotyping
1
2017
274
0.030
Why?
Neoplasm Transplantation
1
1996
227
0.030
Why?
Centrosome
1
2016
59
0.030
Why?
Plasmids
1
1996
343
0.030
Why?
Cell Differentiation
2
1993
1696
0.030
Why?
Smoking Cessation
1
2019
374
0.030
Why?
Mitotic Index
1
2015
26
0.030
Why?
Survival Analysis
1
2018
1206
0.030
Why?
Mice, Nude
1
1996
628
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2018
437
0.030
Why?
Phenotype
2
1993
2784
0.030
Why?
Neoplasm Grading
1
2015
241
0.030
Why?
Computational Biology
1
2018
528
0.030
Why?
Uterine Cervical Neoplasms
1
1996
213
0.030
Why?
Loss of Heterozygosity
1
2013
40
0.030
Why?
Macrophages
1
2020
1259
0.030
Why?
Cell Line, Tumor
2
2012
2700
0.030
Why?
Retinoid X Receptors
1
1993
39
0.030
Why?
Lymphocyte Activation
1
2017
1036
0.030
Why?
DNA Repair
1
2015
184
0.030
Why?
Receptors, Retinoic Acid
1
1993
49
0.030
Why?
Organ Culture Techniques
1
1993
140
0.030
Why?
Models, Molecular
1
2018
1368
0.030
Why?
Cytosol
1
1993
201
0.030
Why?
Drug Resistance
1
1993
158
0.030
Why?
Respiratory Mucosa
1
2015
251
0.030
Why?
United States
2
2011
12137
0.030
Why?
Methylcholanthrene
1
2012
18
0.030
Why?
c-Mer Tyrosine Kinase
1
2012
43
0.030
Why?
Butylated Hydroxytoluene
1
2012
31
0.030
Why?
Immunoprecipitation
1
2012
151
0.020
Why?
Proliferating Cell Nuclear Antigen
1
1992
49
0.020
Why?
Receptors, Cytoplasmic and Nuclear
1
1993
192
0.020
Why?
Intermediate Filament Proteins
1
1992
65
0.020
Why?
Gene Deletion
1
2013
356
0.020
Why?
Administration, Topical
1
2011
137
0.020
Why?
Sleep Apnea Syndromes
1
2012
74
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2012
116
0.020
Why?
Keratins
1
1992
176
0.020
Why?
Mutation, Missense
1
2013
294
0.020
Why?
Antineoplastic Agents
2
2012
1875
0.020
Why?
Administration, Oral
1
2012
725
0.020
Why?
Severity of Illness Index
1
2018
2537
0.020
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
225
0.020
Why?
Carcinoma, Large Cell
1
2010
14
0.020
Why?
RNA Interference
1
2012
431
0.020
Why?
Xenograft Model Antitumor Assays
1
2012
695
0.020
Why?
Cell Division
1
1992
754
0.020
Why?
Aneuploidy
1
2010
84
0.020
Why?
Mice, Inbred Strains
1
2010
398
0.020
Why?
Interleukin-4
1
2010
204
0.020
Why?
Antioxidants
1
2012
529
0.020
Why?
Disease-Free Survival
1
2010
618
0.020
Why?
Cross-Sectional Studies
1
2018
4402
0.020
Why?
Cell Movement
1
2012
863
0.020
Why?
Kaplan-Meier Estimate
1
2010
813
0.020
Why?
Bronchoalveolar Lavage Fluid
1
2010
580
0.020
Why?
Survival Rate
1
2011
1638
0.020
Why?
Proportional Hazards Models
1
2010
1078
0.020
Why?
Skin
1
1991
653
0.020
Why?
Dose-Response Relationship, Drug
1
2010
1836
0.020
Why?
Databases, Nucleic Acid
1
2005
31
0.020
Why?
Case-Control Studies
1
2012
3003
0.020
Why?
Enzymes
1
2005
62
0.020
Why?
Cytokines
1
2012
1824
0.010
Why?
Species Specificity
1
2005
541
0.010
Why?
DNA Replication
1
2005
202
0.010
Why?
Cluster Analysis
1
2005
452
0.010
Why?
Antibodies, Monoclonal
1
2010
1257
0.010
Why?
Age Factors
1
2011
2885
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2005
742
0.010
Why?
Apoptosis
1
2012
2349
0.010
Why?
Young Adult
1
2018
10446
0.010
Why?
Risk Assessment
1
2010
2958
0.010
Why?
Retrospective Studies
1
2016
12521
0.010
Why?
Time Factors
1
2010
6077
0.010
Why?
Echocardiography, Transesophageal
1
1998
90
0.010
Why?
Culture Techniques
1
1991
78
0.010
Why?
Reference Values
1
1991
739
0.010
Why?
Merrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)